Medicine
|
Oncology |
|
ONLINEARCHIVES.ORG > Disciplines > Medicine > Oncology > Prostate cancer > Prognosis > Risk classification > Three-tier risk group classification |
|
|
GROUP 1: LOW RISK AND FIR, GROUP 2: UIR AND SHR, GROUP 3: VHR |
|
. |
Zumsteg
ZS, Zelefsky MJ, Woo KM, Spratt DE, Kollmeier MA, McBride S, Pei
X, Sandler HM, Zhang Z. |
|
|
GLEASON SCORE 3 + 4=7 PROSTATE CANCER WITH MINIMAL QUANTITY (≤5%) OF GLEASON PATTERN 4 ON NEEDLE BIOPSY IS ASSOCIATED WITH LOW-RISK TUMOR |
|
. |
Huang
CC, Kong MX, Zhou M, Rosenkrantz AB, Taneja SS, Melamed J, Deng
FM. |
|
|
The favorable GS 3 + 4 group was defined as having core involvement ≤ 50%, prostate-specific antigen density ≤ 0.2 ng/mL/cm3, and number of positive cores ≤ 2 (maximal 1 core of GS 3 + 4) |
|
. |
Lee
H, Lee IJ, Byun SS, Lee SE, Hong SK. |
|
|
IR PATIENTS WITH A BIOPSY GLEASON SCORE OF 6 APPEAR TO HAVE SIMILAR INTERMEDIATE-TERM BIOCHEMICAL DESEASE-FREE SURVIVAL AS LOW-RISK PATIENTS |
|
. |
Pollard
ME, Hobbs AR, Kwon YS, Katsigeorgis M, Lavery HJ, Levinson A,
Bernstein AN, Collingwood SA, Hall SJ, Samadi DB, Jazayeri SB.
|
|
|
|
|
|
|